tiprankstipranks
Advertisement
Advertisement
Indaptus Therapeutics Announces Major Leadership and Board Changes
PremiumCompany AnnouncementsIndaptus Therapeutics Announces Major Leadership and Board Changes
3M ago
Indaptus Shareholders Approve Major Charter and Capital Changes
Premium
Company Announcements
Indaptus Shareholders Approve Major Charter and Capital Changes
4M ago
Indaptus Therapeutics Reprices Warrants to Bolster Shareholder Support
Premium
Company Announcements
Indaptus Therapeutics Reprices Warrants to Bolster Shareholder Support
5M ago
Indaptus Therapeutics secures new funding and leadership shift
PremiumCompany AnnouncementsIndaptus Therapeutics secures new funding and leadership shift
6M ago
Indaptus Therapeutics reports Q3 EPS ($2.98) vs ($9.04) last year
Premium
The Fly
Indaptus Therapeutics reports Q3 EPS ($2.98) vs ($9.04) last year
8M ago
Indaptus Therapeutics Advances Cancer Treatment with DECOY20 Clinical Study
Premium
Company Announcements
Indaptus Therapeutics Advances Cancer Treatment with DECOY20 Clinical Study
8M ago
Indaptus Therapeutics files to sell 2.16M shares of common stock for holders
PremiumThe FlyIndaptus Therapeutics files to sell 2.16M shares of common stock for holders
11M ago
Indaptus Therapeutics reports Q2 EPS ($9.09) vs ($13.16) last year
Premium
The Fly
Indaptus Therapeutics reports Q2 EPS ($9.09) vs ($13.16) last year
11M ago
Indaptus Therapeutics Secures Approval for Private Placement
Premium
Company Announcements
Indaptus Therapeutics Secures Approval for Private Placement
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100